Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2

21Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Current knowledge indicates that the mammalian target of rapamycin (mTOR) functions as two complexes, mTORC1 and mTORC2, regulating cell growth, proliferation, survival, differentiation, and motility. Recently mSin1 has been identified as a critical component of mTORC2, which is essential for phosphorylation of Akt and other signaling molecules. Studies have shown that rapamycin inhibits phosphorylation of mSin1. However, the underlying mechanism is unknown. Here we found that rapamycin inhibited phosphorylation of mSin1 potently and rapidly. Expression of rapamycin-resistant mutant of mTOR (mTOR-T), but not rapamycin-resistant and kinase dead mutant of mTOR (mTOR-TE), prevented rapamycin from inhibiting mSin1 phosphorylation, suggesting that rapamycin-induced dephosphorylation of mSin1 is mTOR-dependent. Surprisingly, ectopic expression of rapamycin-resistant and constitutively active p70 S6 kinase 1 (S6K1) did not confer resistance to rapamycin-induced dephosphorylation of mSin1. Furthermore, disruption of mTORC1 and mTORC2 by silencing raptor and rictor, respectively, or downregulation of S6K1 or Akt did not induce the dephosphorylation of mSin1 as rapamycin did. However, silencing mTOR or mLST8 mimicked the effect of rapamycin, inhibiting mSin1 phosphorylation. Our findings suggest that rapamycin inhibits mSin1 phosphorylation, which is independent of mTORC1 and mTORC2, but is possibly dependent on a new mTOR complex, which at least contains mTOR and mLST8.

Author supplied keywords

References Powered by Scopus

MTOR signaling in growth control and disease

7006Citations
N/AReaders
Get full text

Intratumor heterogeneity and branched evolution revealed by multiregion sequencing

6414Citations
N/AReaders
Get full text

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

5673Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Drug resistance in pancreatic cancer: Impact of altered energy metabolism

195Citations
N/AReaders
Get full text

Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma

53Citations
N/AReaders
Get full text

A high-throughput kinome screen reveals serum/glucocorticoidregulated kinase 1 as a therapeutic target for NF2-deficient meningiomas

43Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Luo, Y., Liu, L., Wu, Y., Singh, K., Su, B., Zhang, N., … Huang, S. (2015). Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2. Oncotarget, 6(6), 4286–4298. https://doi.org/10.18632/oncotarget.3006

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

83%

Professor / Associate Prof. 2

11%

Researcher 1

6%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 11

50%

Agricultural and Biological Sciences 6

27%

Medicine and Dentistry 4

18%

Veterinary Science and Veterinary Medic... 1

5%

Save time finding and organizing research with Mendeley

Sign up for free